David Beckham’s latest venture, IM8, has secured an impressive $1 billion through an unconventional financing route. General Catalyst’s Customer Value Fund (CVF) is not buying equity but offering loans that tie repayment to future revenue.
The twist? CVF doesn’t seek ownership or dilute IM8's existing stock. Instead, it earns a slice of the company’s income from sales, ensuring Beckham retains control while still getting access to substantial funds. This move could redefine how startups approach financing with more flexible terms.
The vitamin drink company is part of Prenetics, which went public in 2022. Its unique funding model might be appealing to other businesses with steady revenue streams and clear growth potential. The deal also means Grammerly, another recipient of a $1 billion CVF loan, has already set a precedent for such arrangements.
While this approach is intriguing, it remains to be seen how widely adopted this type of funding will become in the startup ecosystem. For now, Beckham can focus on his health drinks and maybe a bit more coffee.
